Cargando…
Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities’ daily life, and the University...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296357/ https://www.ncbi.nlm.nih.gov/pubmed/34204383 http://dx.doi.org/10.3390/ijerph18126526 |
_version_ | 1783725619856539648 |
---|---|
author | Videla, Sebastián Otero, Aurema Martí, Sara Domínguez, M. Ángeles Fabrellas, Nuria Delgado-Hito, M. Pilar Cruz, Imma Tebé, Cristian Vinuesa, Teresa Ardila, Fernando Sancho, Marta Fernández, Esteve Figuerola, Montserrat Ciruela, Francisco |
author_facet | Videla, Sebastián Otero, Aurema Martí, Sara Domínguez, M. Ángeles Fabrellas, Nuria Delgado-Hito, M. Pilar Cruz, Imma Tebé, Cristian Vinuesa, Teresa Ardila, Fernando Sancho, Marta Fernández, Esteve Figuerola, Montserrat Ciruela, Francisco |
author_sort | Videla, Sebastián |
collection | PubMed |
description | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities’ daily life, and the University of Barcelona (UB) was not an exception. Accordingly, we aimed to determine the impact of the SARS-CoV-2 pandemic at the UB. To that end, we performed a cross-sectional study on a sample of 2784 UB members (n = 52,529). Participants answered a brief, ad hoc, online epidemiological questionnaire and provided a nasal swab for reverse transcription polymerase chain reaction (RT-PCR) SARS-CoV-2 analysis and a venous blood sample for SARS-CoV-2 IgG antibody assay. Total prevalence of SARS-CoV-2 infection (positive RT-PCR or positive IgG) was 14.9% (95%CI 13.3 to 17.0%). Forty-four participants (1.6%, 95%CI: 1.2–2.1%) were positive for SARS-CoV-2 RT-PCR. IgG against SARS-CoV-2 was observed in 12.8% (95%CI: 11.6–14.1%) of participants. Overall, while waiting for population vaccination and/or increased herd immunity, we should concentrate on identifying and isolating new cases and their contacts. |
format | Online Article Text |
id | pubmed-8296357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82963572021-07-23 Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain Videla, Sebastián Otero, Aurema Martí, Sara Domínguez, M. Ángeles Fabrellas, Nuria Delgado-Hito, M. Pilar Cruz, Imma Tebé, Cristian Vinuesa, Teresa Ardila, Fernando Sancho, Marta Fernández, Esteve Figuerola, Montserrat Ciruela, Francisco Int J Environ Res Public Health Article The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities’ daily life, and the University of Barcelona (UB) was not an exception. Accordingly, we aimed to determine the impact of the SARS-CoV-2 pandemic at the UB. To that end, we performed a cross-sectional study on a sample of 2784 UB members (n = 52,529). Participants answered a brief, ad hoc, online epidemiological questionnaire and provided a nasal swab for reverse transcription polymerase chain reaction (RT-PCR) SARS-CoV-2 analysis and a venous blood sample for SARS-CoV-2 IgG antibody assay. Total prevalence of SARS-CoV-2 infection (positive RT-PCR or positive IgG) was 14.9% (95%CI 13.3 to 17.0%). Forty-four participants (1.6%, 95%CI: 1.2–2.1%) were positive for SARS-CoV-2 RT-PCR. IgG against SARS-CoV-2 was observed in 12.8% (95%CI: 11.6–14.1%) of participants. Overall, while waiting for population vaccination and/or increased herd immunity, we should concentrate on identifying and isolating new cases and their contacts. MDPI 2021-06-17 /pmc/articles/PMC8296357/ /pubmed/34204383 http://dx.doi.org/10.3390/ijerph18126526 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Videla, Sebastián Otero, Aurema Martí, Sara Domínguez, M. Ángeles Fabrellas, Nuria Delgado-Hito, M. Pilar Cruz, Imma Tebé, Cristian Vinuesa, Teresa Ardila, Fernando Sancho, Marta Fernández, Esteve Figuerola, Montserrat Ciruela, Francisco Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain |
title | Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain |
title_full | Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain |
title_fullStr | Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain |
title_full_unstemmed | Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain |
title_short | Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain |
title_sort | prevalence of sars-cov-2 infection at the university of barcelona during the third covid-19 pandemic wave in spain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296357/ https://www.ncbi.nlm.nih.gov/pubmed/34204383 http://dx.doi.org/10.3390/ijerph18126526 |
work_keys_str_mv | AT videlasebastian prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT oteroaurema prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT martisara prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT dominguezmangeles prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT fabrellasnuria prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT delgadohitompilar prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT cruzimma prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT tebecristian prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT vinuesateresa prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT ardilafernando prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT sanchomarta prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT fernandezesteve prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT figuerolamontserrat prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain AT ciruelafrancisco prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain |